General MedicationsORALGeneric
ETYQA
ESTRADIOL; NORETHINDRONE ACETATE
Standard Dose
1MG;0.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ETYQA is listed in Drugs@FDA under application 214729 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ESTRADIOL; NORETHINDRONE ACETATE Form and strength TABLET;ORAL - 1MG;0.5MG Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2025-06-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview ETYQA is listed in Drugs@FDA under application 214729 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ESTRADIOL; NORETHINDRONE ACETATE Form and strength TABLET;ORAL - 1MG;0.5MG Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2025-06-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.